Nightmares	nightmares	O	O
and	and	O	O
hallucinations	hallucinations	O	S_disease
after	after	O	O
long-term	long-term	O	O
intake	intake	O	O
of	of	O	O
tramadol	tramadol	O	O
combined	combined	O	O
with	with	O	O
antidepressants	antidepressants	S_chemicals	O
.	.	O	O

Tramadol	tramadol	O	O
is	is	O	O
a	a	O	O
weak	weak	O	O
opioid	opioid	S_chemicals	S_disease
with	with	O	O
effects	effects	O	O
on	on	O	O
adrenergic	adrenergic	S_chemicals	O
and	and	O	O
serotonergic	serotonergic	S_chemicals	O
neurotransmission	neurotransmission	O	O
that	that	O	O
is	is	O	O
used	used	O	O
to	to	O	O
treat	treat	O	O
cancer	cancer	O	B_disease
pain	pain	O	I_disease
and	and	O	O
chronic	chronic	O	O
non	non	O	O
malignant	malignant	O	O
pain	pain	O	O
.	.	O	O

This	this	O	O
drug	drug	S_chemicals	O
was	was	O	O
initiated	initiated	O	O
in	in	O	O
association	association	O	O
with	with	O	O
paroxetine	paroxetine	O	O
and	and	O	O
dosulepine	dosulepine	O	O
hydrochloride	hydrochloride	O	O
in	in	O	O
a	a	O	O
tetraparetic	tetraparetic	O	O
patient	patient	O	O
with	with	O	O
chronic	chronic	O	B_disease
pain	pain	O	I_disease
.	.	O	O

Fifty-six	fifty-six	O	O
days	days	O	O
after	after	O	O
initiation	initiation	O	O
of	of	O	O
the	the	O	O
treatment	treatment	O	O
the	the	O	O
patient	patient	O	O
presented	presented	O	O
hallucinations	hallucinations	O	S_disease
that	that	O	O
only	only	O	O
stopped	stopped	O	O
after	after	O	O
the	the	O	O
withdrawal	withdrawal	O	O
of	of	O	O
psycho-active	psycho-active	O	O
drugs	drugs	S_chemicals	O
and	and	O	O
tramadol	tramadol	O	O
.	.	O	O

The	the	O	O
case	case	O	O
report	report	O	O
questions	questions	O	O
the	the	O	O
long	long	O	B_disease
term	term	O	I_disease
use	use	O	O
of	of	O	O
pain	pain	O	O
killers	killers	O	O
combined	combined	O	O
with	with	O	O
psycho-active	psycho-active	O	O
drugs	drugs	S_chemicals	O
in	in	O	O
chronic	chronic	O	O
non	non	O	O
malignant	malignant	O	O
pain	pain	O	O
,	,	O	O
especially	especially	O	O
if	if	O	O
pain	pain	O	O
is	is	O	O
under	under	O	O
control	control	O	O
.	.	O	O

